Plotkin L, Bruzzaniti A, Pianeta R
J Endocr Soc. 2024; 8(10):bvae153.
PMID: 39309123
PMC: 11413583.
DOI: 10.1210/jendso/bvae153.
Joyce K, Wong C, Scriven I, Olson D, Doerge D, Branscum A
Mol Nutr Food Res. 2022; 66(11):e2100974.
PMID: 35319818
PMC: 10906349.
DOI: 10.1002/mnfr.202100974.
Lahmar S, Kessabi K, Banni M, Messaoudi I
Fish Physiol Biochem. 2019; 46(2):747-757.
PMID: 31853706
DOI: 10.1007/s10695-019-00748-w.
Wang Z, Wang D, Yang D, Zhen W, Zhang J, Peng S
Osteoporos Int. 2017; 29(3):535-544.
PMID: 29110063
DOI: 10.1007/s00198-017-4255-1.
Farman H, Windahl S, Westberg L, Isaksson H, Egecioglu E, Schele E
Endocrinology. 2016; 157(8):3242-52.
PMID: 27254004
PMC: 4967117.
DOI: 10.1210/en.2016-1181.
The bone-sparing effects of estrogen and WNT16 are independent of each other.
Moverare-Skrtic S, Wu J, Henning P, Gustafsson K, Sjogren K, Windahl S
Proc Natl Acad Sci U S A. 2015; 112(48):14972-7.
PMID: 26627248
PMC: 4672787.
DOI: 10.1073/pnas.1520408112.
Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.
Adapala N, Holland D, Scanlon V, Barbe M, Langdon W, Tsygankov A
Bone. 2014; 67:1-9.
PMID: 24994594
PMC: 4149851.
DOI: 10.1016/j.bone.2014.06.013.
Morbid obesity attenuates the skeletal abnormalities associated with leptin deficiency in mice.
Turner R, Philbrick K, Wong C, Olson D, Branscum A, Iwaniec U
J Endocrinol. 2014; 223(1):M1-15.
PMID: 24990938
PMC: 4161659.
DOI: 10.1530/JOE-14-0224.
Organic nitrates for osteoporosis: an update.
Hamilton C, Reid L, Jamal S
Bonekey Rep. 2014; 2:259.
PMID: 24422039
PMC: 3722720.
DOI: 10.1038/bonekey.2012.259.
Identification of gender-specific candidate genes that influence bone microarchitecture in chromosome 1.
Mohan S, Hu Y, Edderkaoui B
Calcif Tissue Int. 2012; 92(4):362-71.
PMID: 23263656
PMC: 4955284.
DOI: 10.1007/s00223-012-9687-1.
Estrogen receptor-α expression in neuronal cells affects bone mass.
Ohlsson C, Engdahl C, Borjesson A, Windahl S, Studer E, Westberg L
Proc Natl Acad Sci U S A. 2012; 109(3):983-8.
PMID: 22215598
PMC: 3271867.
DOI: 10.1073/pnas.1111436109.
Mechanical loading-related bone gain is enhanced by tamoxifen but unaffected by fulvestrant in female mice.
Sugiyama T, Galea G, Lanyon L, Price J
Endocrinology. 2010; 151(12):5582-90.
PMID: 20943807
PMC: 3048455.
DOI: 10.1210/en.2010-0645.
Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis.
Mansell J
Int J Gen Med. 2010; 1:51-7.
PMID: 20428406
PMC: 2840536.
DOI: 10.2147/ijgm.s3879.
Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I.
Wang Y, Sakata T, ElAlieh H, Munson S, Burghardt A, Majumdar S
J Endocrinol. 2006; 189(2):279-87.
PMID: 16648295
PMC: 10745196.
DOI: 10.1677/joe.1.06351.
Distribution of estrogen receptors alpha and beta mRNA in mouse urogenital tissues and their expression after oophorectomy and estrogen replacement.
Carley M, Rickard D, Gebhart J, Webb M, Podratz K, Spelsberg T
Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14(2):141-5.
PMID: 12851760
DOI: 10.1007/s00192-002-1020-5.
Animal models for osteoporosis.
Turner R, Maran A, Lotinun S, Hefferan T, Evans G, Zhang M
Rev Endocr Metab Disord. 2001; 2(1):117-27.
PMID: 11704974
DOI: 10.1023/a:1010067326811.
